Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Asterias Biotherapeutics Inc Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Asterias Biotherapeutics Inc Class A market cap is $92.97M.
What is the 52-week high for Asterias Biotherapeutics Inc Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Asterias Biotherapeutics Inc Class A 52 week high is $3.75 as of September 09, 2025.
What is the 52-week low for Asterias Biotherapeutics Inc Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Asterias Biotherapeutics Inc Class A 52 week low is $1.20 as of September 09, 2025.
What was Asterias Biotherapeutics Inc Class A stock price yesterday?
Asterias Biotherapeutics Inc Class A stock price yesterday was $0.945.
What is the PE ratio of Asterias Biotherapeutics Inc Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Asterias Biotherapeutics Inc Class A’s P/E ratio is -3.54.
What is the Price-to-Book ratio of Asterias Biotherapeutics Inc Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Asterias Biotherapeutics Inc Class A P/B ratio is 2.8170.
What is the 50-day moving average of Asterias Biotherapeutics Inc Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Asterias Biotherapeutics Inc Class A 50-day moving average is $1.48.
